Medical economics

GSK, Pfizer to merge consumer healthcare units

Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.

Medications

Pharma giant Pfizer to raise some drug prices

Pfizer said Friday it would raise US prices on 41 drugs in January, reversing a price freeze implemented over the summer in the face of criticism by President Donald Trump.

Medications

Pfizer recalls a type of children's liquid advil

(HealthDay)—One lot of 4-ounce bottles of Children's Advil Suspension Bubble Gum Flavored is being recalled because a packaging problem could lead to an overdose, Pfizer Consumer Healthcare says.

Medications

Pfizer says not part of failed Dutch pregnancy trial

Pfizer Thursday insisted its anti-impotency Viagra drug was not used in a Dutch study seeking to help pregnant women whose babies were not growing properly, halted after 11 infants died.

Medications

Viagra turns 20: chronicle of a global success

Launched in the United States 20 years ago, Viagra has sold in the billions and become an unexpected source of revenue for its maker Pfizer, as well as copycats worldwide.

Medications

Good news, guys: Viagra prices start to tumble today

(HealthDay)—In news that will delight men who've had difficulties in the bedroom, two generic versions of the erectile dysfunction drug Viagra are scheduled to hit the market Monday.

page 1 from 18

Pfizer

Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), antibiotic Zithromax (azithromycin), Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).

Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.

On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.

This text uses material from Wikipedia, licensed under CC BY-SA